- Are Relafen and Cataflam the Same Thing?
- What Are Possible Side Effects of Relafen?
- What Are Possible Side Effects of Cataflam?
- What Is Relafen?
- What Is Cataflam?
- What Drugs Interact with Relafen?
- What Drugs Interact with Cataflam?
- How Should Relafen Be Taken?
- How Should Cataflam Be Taken?
Are Relafen and Cataflam the Same Thing?
Cataflam is also used to treat pain or inflammation caused by ankylosing spondylitis.
The brand name Relafen is no longer available in the U.S. Generic versions may be available.
Side effects of Relafen and Cataflam that are similar include upset stomach, heartburn, stomach pain, diarrhea, constipation, bloating, gas, dizziness, headache, nervousness, skin itching or rash, blurred vision, or ringing in your ears.
Side effects of Cataflam that are different from Relafen include drowsiness.
What Are Possible Side Effects of Relafen?
Common side effects of Relafen include:
- upset stomach,
- stomach pain,
- skin itching or rash,
- blurred vision, or
- ringing in your ears.
Nonsteroidal anti-inflammatory drugs (including Relafen) may rarely increase the risk for a heart attack or stroke. Bleeding from the gastrointestinal tract is another potentially serious side effect of Relafen.
What Are Possible Side Effects of Cataflam?
Common side effects of Cataflam include:
- upset stomach,
- stomach pain,
- skin rash or itching,
- blurred vision, or ringing in your ears.
Tell your doctor if you have unlikely but serious side effects of Cataflam including:
- swelling of the hands or feet (edema),
- sudden or unexplained weight gain,
- hearing changes (such as ringing in the ears),
- mental/mood changes,
- difficult or painful swallowing, or
- unusual tiredness.
What Is Relafen?
Relafen (nabumetone) is a nonsteroidal anti-inflammatory (NSAID) drug used to treat inflammation and pain caused by arthritis. The brand name drug Relafen is no longer available in the U.S. Generic versions may be available.
What Is Cataflam?
Cataflam (diclofenac potassium) is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain or inflammation caused by arthritis or ankylosing spondylitis. Cataflam is available in generic form.
What Drugs Interact With Relafen?
Relafen may interact with antidepressants, blood thinners, lithium, methotrexate, diuretics (water pills), steroids, aspirin or other NSAIDs, or ACE inhibitors.. There are no adequate, well-controlled studies in pregnant women, and Relafen should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. Use during late pregnancy should be avoided because of the known effects of NSAIDs in the fetal cardiovascular system (closure of ductus arteriosus). It is not known whether Relafen is excreted in human milk; a decision should be made whether to discontinue breastfeeding or to discontinue the Relafen.
What Drugs Interact With Cataflam?
Cataflam may interact with blood thinners, cyclosporine, isoniazid, lithium, methotrexate, pronbenecid, rifampin, secobarbital, sertraline, sulfamethoxazole, teniposide, zafirlukast, diuretics, steroids, antifungals, aspirin or other NSAIDs, cholesterol-lowering medicines, or heart or blood pressure medications. Tell your doctor all medications and supplements you use. During pregnancy, Cataflam should be used only when prescribed. Tell your doctor if you are pregnant or if you plan to become pregnant. This drug may cause miscarriage. It is not recommended for use during the first and last trimesters of pregnancy due to possible harm to the fetus and interference with normal labor/delivery. This drug passes into breast milk. While there have been no reports of harm to nursing infants, consult your doctor before breastfeeding.
How Should Relafen Be Taken?
Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals.
How Should Cataflam Be Taken?
For treatment of pain the recommended dosage of Cataflam is 50 mg, taken two to four times daily, depending on the cause.
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
FDA. Relafen Product Information.
Novartis. Cataflam Product Information.